Browse > Article
http://dx.doi.org/10.5483/BMBRep.2010.43.12.781

Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity  

Kang, Eun-Ah (Nanomedical Science, Institute for Cancer Research, Severance Biomedical Science Institute, Yonsei University College of Medicine)
Yun, Chae-Ok (Nanomedical Science Institute for Cancer Research, Severance Biomedical Science Institute, Yonsei University College of Medicine)
Publication Information
BMB Reports / v.43, no.12, 2010 , pp. 781-788 More about this Journal
Abstract
An often overlooked issue in the field of adenovirus (Ad)-mediated cancer gene therapy is its limited capacity for effective systemic delivery. Although primary tumors can be treated effectively with intralesional injection of conventional Ad vectors, systemic metastasis is difficult to cure. Systemic administration of conventional naked Ads leads to acute accumulation of Ad particles in the liver, induction of neutralizing antibody, short blood circulation half-life, non-specific biodistribution in undesired organs, and low selective accumulation in the target disease site. Versatile strategies involving the modification of viral surfaces with polymers and nanomaterials have been designed for the purpose of maximizing Ad anti-tumor activity and specificity by systemic administration. Integration of viral and non-viral nanomaterials will substantially advance both fields, creating new concepts in gene therapeutics. This review focuses on current advances in the development of smart Ad hybrid nanocomplexes based on various design-based strategies for optimal Ad systemic administration.
Keywords
Adenovirus; Nanocomplex; Nanomaterial; Oncolytic adenovirus; PEG; pHPMA;
Citations & Related Records

Times Cited By Web Of Science : 4  (Related Records In Web of Science)
Times Cited By SCOPUS : 7
연도 인용수 순위
1 Hofherr, S. E., Mok, H., Gushiken, F. C., Lopez, J. A. and Barry, M. A. (2007) Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum. Gene Ther. 18, 837-848.   DOI   ScienceOn
2 Ogawara, K., Rots, M. G., Kok, R. J., Moorlag, H. E., Van Loenen, A. M., Meijer, D. K., Haisma, H. J. and Molema, G. (2004) A nsovel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum. Gene Ther. 15, 433-443.   DOI   ScienceOn
3 Park, J. W., Mok, H. and Park, T. G. (2008) Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus. Biochem. Biophys. Res. Commun. 366, 769-774.   DOI   ScienceOn
4 Bonsted, A., Engesaeter, B. O., Hogset, A., Maelandsmo, G. M., Prasmickaite, L., D'Oliveira, C., Hennink, W. E., van Steenis, J. H. and Berg, K. (2006) Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor. J. Gene Med. 8, 286-297.   DOI   ScienceOn
5 Morrison, J., Briggs, S. S., Green, N., Fisher, K., Subr, V., Ulbrich, K., Kehoe, S. and Seymour, L. W. (2008) Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor. Mol. Ther. 16, 244-251.   DOI   ScienceOn
6 Maeda, M., Kida, S., Hojo, K., Eto, Y., Gaob, J. Q., Kurachi, S., Sekiguchi, F., Mizuguchi, H., Hayakawa, T., Mayumi, T., Nakagawa, S. and Kawasaki, K. (2005) Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells. Bioorg. Med. Chem. Lett. 15, 621-624.   DOI   ScienceOn
7 Oh, I. K., Mok, H. and Park, T. G. (2006) Folate immobilized and PEGylated adenovirus for retargeting to tumor cells. Bioconjug. Chem. 17, 721-727.   DOI   ScienceOn
8 Eto, Y., Gao, J. Q., Sekiguchi, F., Kurachi, S., Katayama, K., Maeda, M., Kawasaki, K., Mizuguchi, H., Hayakawa, T., Tsutsumi, Y., Mayumi, T. and Nakagawa, S. (2005) PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J. Gene Med. 7, 604-612.   DOI   ScienceOn
9 Gao, J. Q., Eto, Y., Yoshioka, Y., Sekiguchi, F., Kurachi, S., Morishige, T., Yao, X., Watanabe, H., Asavatanabodee, R., Sakurai, F., Mizuguchi, H., Okada, Y., Mukai, Y., Tsutsumi, Y., Mayumi, T., Okada, N. and Nakagawa, S. (2007) Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration. J. Control Release 122, 102-110.   DOI   ScienceOn
10 Gressner, A. M. and Pfeiffer, T. (1986) Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes. J. Clin. Chem. Clin. Biochem. 24, 821-829.
11 Shayakhmetov, D. M., Li, Z. Y., Ni, S. and Lieber, A. (2004) Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78, 5368-5381.   DOI
12 Barton, K. N., Stricker, H., Kolozsvary, A., Kohl, R., Heisey, G., Nagaraja, T. N., Zhu, G., Lu, M., Kim, J. H., Freytag, S. O. and Brown, S. L. (2006) Polyethylene glycol (molecular weight 400 DA) vehicle improves gene expression of adenovirus mediated gene therapy. J. Urol. 175, 1921-1925.   DOI   ScienceOn
13 Fisher, K. D., Stallwood, Y., Green, N. K., Ulbrich, K., Mautner, V. and Seymour, L. W. (2001) Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther. 8, 341-348.   DOI
14 Green, N. K., Morrison, J., Hale, S., Briggs, S. S., Stevenson, M., Subr, V., Ulbrich, K., Chandler, L., Mautner, V., Seymour, L. W. and Fisher, K. D. (2008) Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. J. Gene Med. 10, 280-289.   DOI   ScienceOn
15 Hofherr, S. E., Shashkova, E. V., Weaver, E. A., Khare, R. and Barry, M. A. (2008) Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol. Ther. 16, 1276-1282.   DOI   ScienceOn
16 Pearce, O. M., Fisher, K. D., Humphries, J., Seymour, L. W., Smith, A. and Davis, B. G. (2005) Glycoviruses: chemical glycosylation retargets adenoviral gene transfer. Angew. Chem. Int. Ed. Engl. 44, 1057-1061.   DOI   ScienceOn
17 Lee, G. K., Maheshri, N., Kaspar, B. and Schaffer, D. V. (2005) PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnol. Bioeng. 92, 24-34.   DOI   ScienceOn
18 Jung, Y., Park, H. J., Kim, P. H., Lee, J., Hyung, W., Yang, J., Ko, H., Sohn, J. H., Kim, J. H., Huh, Y. M., Yun, C. O. and Haam, S. (2007) Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells. J. Control Release 123, 164-171.   DOI   ScienceOn
19 Yao, X., Yoshioka, Y., Morishige, T., Eto, Y., Watanabe, H., Okada, Y., Mizuguchi, H., Mukai, Y., Okada, N. and Nakagawa, S. (2009) Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis. Gene Ther. 16, 1395-1404.   DOI   ScienceOn
20 Chan, P., Kurisawa, M., Chung, J. E. and Yang, Y. Y. (2007) Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials 28, 540-549.   DOI   ScienceOn
21 Doronin, K., Shashkova, E. V., May, S. M., Hofherr, S. E. and Barry, M. A. (2009) Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Hum. Gene Ther. 20, 975-988.   DOI   ScienceOn
22 Kiang, A., Hartman, Z. C., Everett, R. S., Serra, D., Jiang, H., Frank, M. M. and Amalfitano, A. (2006) Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol. Ther. 14, 588-598.   DOI   ScienceOn
23 Zhang, Y. A., Nemunaitis, J., Samuel, S. K., Chen, P., Shen, Y. and Tong, A. W. (2006) Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. Cancer Res. 66, 9736-9743.   DOI   ScienceOn
24 Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., Randlev, B., Gillenwater, A. M., Bruso, P., Kaye, S. B., Hong, W. K. and Kirn, D. H. (2000) A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6, 879-885.   DOI   ScienceOn
25 Nemunaitis, J., Ganly, I., Khuri, F., Arseneau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S. and Kirn, D. (2000) Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res. 60, 6359-6366.
26 Singh, R. and Kostarelos, K. (2009) Designer adenoviruses for nanomedicine and nanodiagnostics. Trends. Biotechnol. 27, 220-229.   DOI   ScienceOn
27 Li, F., Zhang, Z. P., Peng, J., Cui, Z. Q., Pang, D. W., Li, K., Wei, H. P., Zhou, Y. F., Wen, J. K. and Zhang, X. E. (2009) Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles. Small 5, 718-726.   DOI   ScienceOn
28 Thompson, D. H. (2008) Adenovirus in a synthetic membrane wrapper: an example of hybrid vigor? ACS Nano 2, 821-826.   DOI   ScienceOn
29 Fisher, K. D. and Seymour, L. W. (2010) HPMA copolymers for masking and retargeting of therapeutic viruses. Adv. Drug. Deliv. Rev. 62, 240-245.   DOI   ScienceOn
30 Yoo, J. Y., Kim, J. H., Kim, J., Huang, J. H., Zhang, S. N., Kang, Y. A., Kim, H. and Yun, C. O. (2008) Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition. Gene Ther. 15, 635-651.   DOI   ScienceOn
31 Zhao, L., Dong, A., Gu, J., Liu, Z., Zhang, Y., Zhang, W., Wang, Y., He, L., Qian, C., Qian, Q. and Liu, X. (2006) The anti-tumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther. 13, 1011-1022.   DOI   ScienceOn
32 Steinwaerder, D. S., Carlson, C. A., Otto, D. L., Li, Z. Y., Ni, S. and Lieber, A. (2001) Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector. Nat. Med. 7, 240-243.   DOI   ScienceOn
33 Chengalvala, M. V., Lubeck, M. D., Selling, B. J., Natuk, R. J., Hsu, K. H., Mason, B. B., Chanda, P. K., Bhat, R. A., Bhat, B. M., Mizutani, S. (1991) Adenovirus vectors for gene expression. Curr. Opin. Biotechnol. 2, 718-722.   DOI   ScienceOn
34 Alemany, R., Balague, C. and Curiel, D. T. (2000) Replicative adenoviruses for cancer therapy. Nat. Biotechnol. 18, 723-727.   DOI   ScienceOn
35 Green, N. K., Herbert, C. W., Hale, S. J., Hale, A. B., Mautner, V., Harkins, R., Hermiston, T., Ulbrich, K., Fisher, K. D. and Seymour, L. W. (2004) Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther. 11, 1256-1263.   DOI   ScienceOn
36 Choi, I. K., Lee, Y. S., Yoo, J. Y., Yoon, A. R., Kim, H., Kim, D. S., Seidler, D. G., Kim, J. H. and Yun, C. O. (2010) Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy. Gene Ther. 17, 190-201.   DOI   ScienceOn
37 Gomes, E. M., Rodrigues, M. S., Phadke, A. P., Butcher, L. D., Starling, C., Chen, S., Chang, D., Hernandez-Alcoceba, R., Newman, J. T., Stone, M. J. and Tong, A. W. (2009) Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells. Clin. Cancer Res. 15, 1317-1325.   DOI   ScienceOn
38 Chen, L., Chen, D., Gong, M., Na, M., Li, L., Wu, H., Jiang, L., Qian, Y., Fang, G. and Xue, X. (2009) Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Cancer Lett. 284, 141-148.   DOI   ScienceOn
39 Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L. and Kirn, D. (2000) An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat. Med. 6, 1134-1139.   DOI   ScienceOn
40 Kim, J. H., Lee, Y. S., Kim, H., Huang, J. H., Yoon, A. R. and Yun, C. O. (2006) Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J. Natl. Cancer Inst. 98, 1482-1493.   DOI   ScienceOn
41 Kim, P. H., Kim, T. I., Yockman, J. W., Kim, S. W. and Yun, C. O. (2010) The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials 31, 1865-1874.   DOI   ScienceOn
42 Park, Y., Kang, E., Kwon, O. J., Hwang, T., Park, H., Lee, J. M., Kim, J. H. and Yun, C. O. (2010) Ionically crosslinked Ad/chitosan nanocomplexes processed by electro-spinning for targeted cancer gene therapy. J. Control Release. S0168-3659(10)00475-X [pii] 10.1016/j.jconrel.2010.06.027.   DOI   ScienceOn
43 Mok, H., Park, J. W. and Park, T. G. (2008) Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconjug. Chem. 19, 797-801.   DOI   ScienceOn
44 Park, J. W., Mok, H. and Park, T. G. (2010) Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction. J. Control Release 142, 238-244.   DOI   ScienceOn
45 Sarkar, D., Lebedeva, I. V., Su, Z. Z., Park, E. S., Chatman, L., Vozhilla, N., Dent, P., Curiel, D. T. and Fisher, P. B. (2007) Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Cancer Res. 67, 5434-5442.   DOI   ScienceOn
46 Sarkar, D., Su, Z. Z. and Fisher, P. B. (2006) Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy. Cell Cycle. 5, 1531-1536.   DOI
47 Cattaneo, R., Miest, T., Shashkova, E. V. and Barry, M. A. (2008) Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat. Rev. Microbiol. 6, 529-540.   DOI   ScienceOn
48 Saini, V., Martyshkin, D. V., Mirov, S. B., Perez, A., Perkins, G., Ellisman, M. H., Towner, V. D., Wu, H., Pereboeva, L., Borovjagin, A., Curiel, D. T. and Everts, M. (2008) An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Small 4, 262-269.   DOI   ScienceOn
49 Lanciotti, J., Song, A., Doukas, J., Sosnowski, B., Pierce, G., Gregory, R., Wadsworth, S. and O'Riordan, C. (2003) Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Mol. Ther. 8, 99-107.   DOI   ScienceOn